| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/28/1989 | CA1250587A1 Method and agents for measuring protein aging |
| 02/28/1989 | CA1250523A1 Conjugates elaborated by binding a ligant to an isoluble medium, preparation process and biological uses |
| 02/23/1989 | WO1989001630A1 Procedure for relieving cell mixtures and tissues of unwanted populations |
| 02/23/1989 | WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 02/23/1989 | WO1989001628A1 Monoclonal antibodies reactive with cytomegalovirus glycoprotein a |
| 02/23/1989 | WO1989001519A1 Human mannose binding protein |
| 02/23/1989 | WO1989001517A1 Vector for integration site independent gene expression in mammalian host cells |
| 02/23/1989 | WO1989001512A1 A sponge enzyme having transglutaminase-like activity |
| 02/23/1989 | WO1989001511A1 Suppressive t lymphocyte cell lines and supernatant derivative thereof |
| 02/23/1989 | WO1989001495A1 Cholesterol-level depressant |
| 02/23/1989 | WO1989001493A1 Polypeptides with laminin activity |
| 02/23/1989 | WO1989001492A1 Novel polypeptide and method for preparing the same |
| 02/23/1989 | WO1989001490A2 Biologically active molecules |
| 02/23/1989 | WO1989001489A1 Control of angiogenesis and compositions and methods therefor |
| 02/23/1989 | WO1989001488A1 Renin inhibiting peptides with nonpeptide linkages |
| 02/23/1989 | WO1989001487A1 Removal of n-terminal acylated amino acid residues from polypeptides |
| 02/23/1989 | WO1989001486A1 Biologically active bactericidal/permeability-increasing protein fragments |
| 02/23/1989 | WO1989001343A1 Cationized antibodies for delivery through the blood-brain barrier |
| 02/23/1989 | WO1989001341A1 Methods and compositions for the treatment of lung conditions |
| 02/23/1989 | WO1989001340A1 Method for treating malignancy and autoimmune disorders in humans |
| 02/23/1989 | WO1989001339A1 Hyper-immune globulin against hiv |
| 02/23/1989 | WO1989001338A1 Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
| 02/23/1989 | WO1989001336A1 Micro-size fibrinolytic plasmin |
| 02/23/1989 | WO1989000582A3 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 02/23/1989 | DE3727011A1 Type II diabetes mellitus selective treatment - using DES-B25-30-hexa:peptide insulin or corresp. opt. N-substd. B24 amide(s) |
| 02/22/1989 | EP0304311A1 Complex of polyethylene glycol and tissue plasminogen activator |
| 02/22/1989 | EP0304291A1 Dosage form using an antagonist to gamma interferon to control MHC-associated autoimmune disease |
| 02/22/1989 | EP0304279A2 Peptide determinant associated with immunity |
| 02/22/1989 | EP0303859A2 Cloning of DNA encoding antibacterial polypeptide precursor and expression of the precursor |
| 02/22/1989 | EP0303858A2 Cloning of dna encoding antibacterial polypeptide precursor and expression of the precursor |
| 02/22/1989 | EP0303746A1 Stabilization of growth promoting hormones |
| 02/22/1989 | EP0303692A1 Cloning of lfa-1 |
| 02/22/1989 | EP0151593B1 Enzyme derivatives |
| 02/21/1989 | US4806680 3-halovinylglycine antibacterial agents |
| 02/21/1989 | US4806629 Hybric cell line-for diagnosis and therapy |
| 02/21/1989 | US4806628 Specific binding; diagnosis and treatment of melanomas |
| 02/21/1989 | US4806626 α-amylase inhibitor |
| 02/21/1989 | US4806569 Administering metabolites of linoleic and alpha-linolenic acids; antidiabetic agents, antiallergens, cancer agents, alcoholism |
| 02/21/1989 | US4806525 Formulation comprising gelatin and glycine for treating the dryness of skin |
| 02/21/1989 | US4806524 Stable erythropoietin preparation and process for formulating the same |
| 02/21/1989 | US4806523 Cartilage-inducing factors |
| 02/21/1989 | US4806494 Monoclonal antibody against ovarian cancer cells (OVB-3) |
| 02/21/1989 | US4806492 Polypeptide tumor inhibitors and antibodies thereto |
| 02/21/1989 | US4806473 Using carboxypeptidase y to cleave protective groups; producing di-, tri- and tetrapeptides |
| 02/21/1989 | US4806349 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods |
| 02/21/1989 | US4806347 Antitumor agents, viricides in humans |
| 02/21/1989 | US4806346 Method for isolation of antigen specific immunoglobulin |
| 02/21/1989 | US4806343 Cryogenic protectant for proteins |
| 02/21/1989 | US4806336 Human intestinal hormone and its use |
| 02/21/1989 | CA1250400A1 Peptides having influence on memory processes, processes for producing them and pharmaceutical compositions containing them |
| 02/21/1989 | CA1250398A1 Tri-tetra- and pentapeptides, their preparation, and pharmaceutical products containing same |
| 02/21/1989 | CA1250234A1 Clinical use of somatostatin analogues |
| 02/21/1989 | CA1250233A1 Moraxella bovis bacterin |
| 02/15/1989 | EP0303540A1 Factor VIII analog, process for its preparation and composition containing it |
| 02/15/1989 | EP0303538A2 Protein with a vascular activity, derived from monocytes and its analogues, process for its extraction and their uses as therapeutic agents and for the preparation of antibodies |
| 02/15/1989 | EP0303516A2 Topically active compositions of double-stranded RNAs |
| 02/15/1989 | EP0303488A2 Biologically active molecules |
| 02/15/1989 | EP0303483A2 Novel lymphokine and compositions thereof |
| 02/15/1989 | EP0303463A2 Method to control leukocyte extravasation |
| 02/15/1989 | EP0303380A2 Crystalline L-carnosine zinc complex and production thereof |
| 02/15/1989 | EP0303329A1 A process for isolating coagulation factors, and adsorbent material suitable therefor |
| 02/15/1989 | EP0303309A2 A genus-specific Listeria antigen identified by monoclonal antibodies |
| 02/15/1989 | EP0303308A1 Preparation for preventing or combating complications in diabetes |
| 02/15/1989 | EP0303251A2 Injection composition containing modified tPA |
| 02/15/1989 | EP0303243A2 Use of atrial natriuretic factor (ANF), fragments and analogues thereof, for the treatment of cardiac disorders |
| 02/15/1989 | EP0303233A2 Human reg protein |
| 02/15/1989 | EP0303088A2 Purified IgM |
| 02/15/1989 | EP0303064A2 Phospholipid affinity purification of factor VIII:C |
| 02/15/1989 | EP0303033A2 Molecular cloning and characterization of a further gene sequence coding for human relaxin |
| 02/15/1989 | EP0303028A1 Method for preparing single chain urokinase |
| 02/15/1989 | EP0302925A1 A method for producing factor viii in high yield |
| 02/15/1989 | EP0302862A1 Treatment of cancers with gamma interferon |
| 02/15/1989 | EP0143832B1 Modified crosslinked stroma-free tetrameric hemoglobin |
| 02/15/1989 | CN1031088A Conjugates of superoxide dismutase couples tod high molecular weight polyalkylene glycols |
| 02/14/1989 | US4804745 Cold water soluble hydrolyzed collagen |
| 02/14/1989 | US4804744 Osteogenic factors |
| 02/14/1989 | US4804742 Osteoporosis treatment of extended duration |
| 02/14/1989 | US4804676 Propioxatins a and b |
| 02/14/1989 | US4804672 2-oxo-imidazolidine derivatives as agents for treatment of kidney diseases |
| 02/14/1989 | US4804650 Diuretics, vasodilators |
| 02/14/1989 | CA1250098A1 Ester derivatives of antibiotic l 17046 |
| 02/14/1989 | CA1250096A1 Process for preparing antibiotic l 17392 (deglucoteicoplanin) |
| 02/14/1989 | CA1250095A1 Carboxylic acid ester derivatives of deglucoteicoplanin |
| 02/14/1989 | CA1250092A1 Polypeptide diuretic/vasodilators |
| 02/14/1989 | CA1250091A1 Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions |
| 02/14/1989 | CA1250090A1 Pharmaceutical composition having an excellent absorption property |
| 02/14/1989 | CA1249984A1 Centrifugal microconcentrator and methods for its use |
| 02/14/1989 | CA1249967A1 Stimulation of phagocytosis with somatostatin |
| 02/09/1989 | WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain |
| 02/09/1989 | WO1989001033A1 Conjugates of superoxide dismutase |
| 02/09/1989 | WO1989001031A1 Method for the isolation of active enzyme(s) from krill tissue |
| 02/09/1989 | WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 02/09/1989 | WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents |
| 02/09/1989 | WO1989000854A1 Methods for increasing extracellular adenosine and for stabilizing mast cells |
| 02/09/1989 | WO1989000805A2 Treatment of infections with tumor necrosis factor |
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
| 02/09/1989 | DE3825242A1 Histidinylamino compounds substituted by sulphur-containing groups |
| 02/09/1989 | DE3710309A1 Vascular anticoagulant proteins, DNA which encode these, process for their preparation and their use |
| 02/08/1989 | EP0302847A2 Physically stable composition and method of use thereof for osseous repair |
| 02/08/1989 | EP0302769A1 Lipid emulsion for parenteral or enteral nutrition |